WO2012108743A3 - Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait des graines de pharbitis blanc - Google Patents

Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait des graines de pharbitis blanc Download PDF

Info

Publication number
WO2012108743A3
WO2012108743A3 PCT/KR2012/001077 KR2012001077W WO2012108743A3 WO 2012108743 A3 WO2012108743 A3 WO 2012108743A3 KR 2012001077 W KR2012001077 W KR 2012001077W WO 2012108743 A3 WO2012108743 A3 WO 2012108743A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
brain cancer
cosmetic composition
pharbitis seed
treating brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/001077
Other languages
English (en)
Korean (ko)
Other versions
WO2012108743A2 (fr
Inventor
황성연
정경채
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Bio Medical Science Institute Co Ltd
Original Assignee
Korea Bio Medical Science Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Bio Medical Science Institute Co Ltd filed Critical Korea Bio Medical Science Institute Co Ltd
Publication of WO2012108743A2 publication Critical patent/WO2012108743A2/fr
Publication of WO2012108743A3 publication Critical patent/WO2012108743A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q90/00—Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une nouvelle utilisation d'un extrait des graines de Pharbitis blanc, et concerne notamment une composition pour prévenir et guérir le cancer du cerveau, la composition comprenant un extrait éthanolique des graines de Pharbitis blanc en tant qu'ingrédient actif, et une composition cosmétique pour prévenir le cancer du cerveau, la composition cosmétique comprenant l'extrait éthanolique des graines de Pharbitis blanc, qui comprend un additif de supplément cosmétique acceptable en cosmétologie en tant qu'ingrédient actif. La composition et la composition cosmétique pour traiter le cancer du cerveau selon la présente invention sont efficaces pour inhiber la croissance et provoquer la mort des cellules cancéreuses; cela permet de les utiliser efficacement pour prévenir et guérir le cancer du cerveau.
PCT/KR2012/001077 2011-02-11 2012-02-13 Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait des graines de pharbitis blanc Ceased WO2012108743A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2011-0012205 2011-02-11
KR1020110012205A KR20120092267A (ko) 2011-02-11 2011-02-11 백축 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물

Publications (2)

Publication Number Publication Date
WO2012108743A2 WO2012108743A2 (fr) 2012-08-16
WO2012108743A3 true WO2012108743A3 (fr) 2012-12-27

Family

ID=46639098

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/001077 Ceased WO2012108743A2 (fr) 2011-02-11 2012-02-13 Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait des graines de pharbitis blanc

Country Status (2)

Country Link
KR (1) KR20120092267A (fr)
WO (1) WO2012108743A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014069693A1 (fr) * 2012-10-31 2014-05-08 주식회사 한국전통의학연구소 Composition pour traiter le cancer du pancréas et composition cosmétique contenant un extrait de semence de pharbitidis
WO2014069687A1 (fr) * 2012-10-31 2014-05-08 주식회사 한국전통의학연구소 Composition pour traiter le cancer rénal et composition cosmétique contenant un extrait de semence de pharbitidis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790464B2 (en) * 2003-01-16 2004-09-14 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790464B2 (en) * 2003-01-16 2004-09-14 Healthaid Enterprise Pte. Ltd. Herbal compositions for prostate conditions

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KANG, TAK LIM.: "Study on anticancer activity of various herb medicines.", J. RESEARCH INSTITUTE OF KOREAN MEDICINE, DAEJEON UNIVERSITY., vol. 3, no. 2, February 1995 (1995-02-01), pages 315 - 321 *
LI, ZUO-QING.: "Traditional Chinese Medicine for Primary Liver Cancer.", WORLD J GASTROENTEROL., vol. 4, no. 4, August 1998 (1998-08-01), pages 360 - 364 *
PARK, KEUNHYOUNG ET AL.: "Selection of Oriental Medicinal Plants for Screening of Anticancer Agents.", KOREAN JOURNAL OF BIOTECHNOLOGY AND BIOENGINEERING., vol. 22, no. 3, June 2007 (2007-06-01), pages 139 - 145 *
SOHN, H. Y. ET AL.: "Anti-Proliferative Activities of Solid-State Fermented medicinal Herbs Using Phellinus baumii against Human Colorectal HCT116 Cell.", JOURNAL OF LIFE SCIENCE., vol. 20, no. 8, 2010, pages 1268 - 1275 *

Also Published As

Publication number Publication date
KR20120092267A (ko) 2012-08-21
WO2012108743A2 (fr) 2012-08-16

Similar Documents

Publication Publication Date Title
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
PH12012501390A1 (en) Fatty acid fumarate derivatives and their uses
NZ732777A (en) Ionizable cationic lipid for rna delivery
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MX363465B (es) Tratamiento de la grasa submental.
WO2012040804A3 (fr) Combinaisons synergiques de triazoles, strobilurines et de benzimidazoles, leurs utilisations, formulations, leurs procédés de production et leurs applications
MX381044B (es) Composición que contiene extracto o fracción de plantas del género justicia.
WO2013123249A3 (fr) Formulations et méthodes de traitement d'états de l'oreille
MX2012013478A (es) Composicion para evitar perdida del cabello o estimular crecimiento del cabello.
EP2575842A4 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
WO2012134169A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait de semence de gleditsiae
WO2012112232A8 (fr) Méthodes et compositions pour le traitement de la β-thalassémie et de la drépanocytose
WO2012108749A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de graines de pharbitis
WO2012108748A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin
WO2013100718A3 (fr) Composition pharmaceutique permettant de prévenir ou de traiter des maladies inflammatoires ou l'asthme, contenant un extrait de lagerstroemia ovalifolia ou une fraction de celle-ci en tant que principe actif
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena
WO2012134172A3 (fr) Composition contenant, comme ingrédient actif, une fraction d'acétate d'éthyle de schisandra chinensis baill, ou wuweizisu c séparée de la fraction, pour prévenir ou traiter l'obésité
WO2012108743A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait des graines de pharbitis blanc
IN2014MN01933A (fr)
WO2012108746A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de racine de rubia cordifolia
WO2012108744A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de la fleur inula
WO2012108745A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de gleditsiae semen
MY162943A (en) Sense-improving agent
WO2012108742A3 (fr) Composition et l'alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de fleur tussilago farfara
WO2012099420A3 (fr) Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12744421

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12744421

Country of ref document: EP

Kind code of ref document: A2